Clinical Trial Update: Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of chemotherapy, radiotherapy, and bevacizumab in unresectable stage III non-small cell lung cancer was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-01-13